Assessing Lung Ultrasound to Guide Antibiotic Use in Hospitalized Children and Teens with Lung Infections
Led by American University of Beirut Medical Center · Updated on 2026-07-02
176
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
This research aims to evaluate whether using lung ultrasound LUS can help doctors reduce the length of antibiotic treatment in children and adolescents hospitalized with lower respiratory tract infections LRTIs. The trial compares LUS-guided antibiotic decisions to standard care, which may include chest X-rays. The study focuses on improving antibiotic use to prevent resistance and reduce side effects in pediatric patients.
Participants are randomly assigned to one of two groups. The LUS group receives a lung ultrasound within 24 hours of enrollment to guide antibiotic use, including decisions on when to stop treatment. The standard care group receives usual hospital care, which may involve chest X-rays and clinical evaluations. Follow-up ultrasounds may be performed within 48 hours or before discharge to monitor lung conditions.
Throughout the study, participants will be monitored for antibiotic duration, hospital stay length, and need for further treatments or readmissions. The primary outcome is the rate of antibiotic prescriptions at discharge, assessed up to 30 days after enrollment. The study involves clinical assessments, lung ultrasounds, and tracking of hospital outcomes to understand the impact of LUS on treatment decisions.
CONDITIONS
Brief Title
Effect of Pediatric Lung Ultrasound on Antibiotic Prescriptions in Hospitalized Children and Adolescents With Lower Respiratory Tract Infections. A Randomized Controlled Trial.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Currently admitted to the pediatric ward or emergency department within 24 hours due to lower respiratory tract infections
You will not qualify if you...
Sickle cell disease (SCD)
Receiving chemotherapy or immunosuppressive therapy except systemic corticosteroids use of 5 days or less
Cystic fibrosis and other chronic lung diseases except asthma
Pre-existing or congenital neurologic, metabolic, or cardiac conditions
Hospitalized within the previous month
Suspected foreign body aspiration
Received antibiotic therapy within the previous week
Patients admitted under the principal investigator's care
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Treatment
Duration - Duration of hospital stay
Participants receive either a real lung ultrasound or a sham ultrasound within 24 hours to guide antibiotic treatment decisions. Follow-up ultrasounds may occur within 48 hours or before discharge to monitor lung condition.
Initial ultrasound within 24 hours and follow-up scans as needed
Follow-up
Duration - Up to 30 days after discharge
Researchers monitor participants for antibiotic use, hospital stay length, complications, and readmissions up to 30 days after enrollment.
Follow-up assessments during hospital stay and after discharge
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Similar Trials
Assessing Lung Ultrasound to Guide Antibiotic Use in Hospitalized Children and Teens with Lung Infections
Study of an Electronic Clinical Decision Support Tool for Treating Lower Respiratory Tract Infection
in Hospitals in Southern Sri Lanka
A Stepped-Wedge Cluster Randomized Trial
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Effect of paediatric lung ultrasound on antibiotic prescriptions in hospitalised children and adolescents with lower respiratory tract infections: protocol for a randomised, sham-controlled trial (PLUS-AP trial).